A large European industrial corporation establishes a EUR 150 million corporate venture unit. The mandate, as documented in the founding governance paper, states that the unit will pursue both strategic and financial objectives. The investment team is instructed to identify companies that are relevant to the corporation’s technology roadmap and capable of delivering strong financial returns.
Eighteen months in, a deal arrives. A Series B climate-tech company in the energy storage space. The technology is highly relevant: if it scales, it could disrupt part of the parent corporation’s existing product line. The financial case is also strong: the round is oversubscribed, the lead investor is credible, and the valuation is reasonable relative to comparables. Two business unit heads are excited by the strategic angle. The CFO is supportive of the return profile. The CVC team brings it to the investment committee.
The IC discussion runs for three hours. One board member argues they should not invest because disrupting their own product line is strategically undesirable. Another argues they must invest precisely because that disruption is coming regardless. The CFO wants a specific commercial partnership structure baked into the investment terms before they commit. The founder is unwilling to offer that on the timeline available. The round closes without them.
Six months later, that same company closes a series of enterprise agreements with three of the parent corporation’s direct competitors. The CVC team is asked to explain what happened.
What happened is not a failure of analysis or deal sourcing. It is a failure of mandate design. The unit had two masters and no sequencing logic for when they disagreed. The IC discussion was three hours of genuine disagreement, not because the participants were wrong, but because the mandate gave them no mechanism for resolution.
How Mandate Ambiguity Forms, What It Costs, and How to Sequence It
How CVC mandate ambiguity forms
The governance dynamics that produce dual mandates without sequencing are well documented. Most CVC units are established during periods of corporate optimism about innovation: a CEO or board decides that the company needs a venture capability, builds a business case that requires the unit to serve both innovation and financial return objectives, and launches with a mandate that reflects both imperatives without specifying which takes precedence.
The business case logic is understandable. A unit that generates only strategic insight is difficult to justify to a CFO. A unit that generates only financial returns is difficult to justify to a chief innovation officer or head of strategy. The dual mandate satisfies both conversations during setup. It then fails both objectives in operation.
Research from the Stanford Graduate School of Business, based on in-depth interviews with leaders of 164 CVC units, found that parent company executives play a pivotal role in IC approvals across most CVC structures. This integration creates the conditions for mandate conflict: the same IC that is supposed to evaluate a deal on its investment merits also includes executives whose primary accountability is to the parent corporation’s strategic and operational interests. When those interests diverge from what the deal analysis recommends, the IC has no decision rule.
The SVB and Counterpart Ventures 2025 State of CVC report, drawing on a survey of global CVC funds, identified corporate prioritisation and bureaucratic decision-making as two of the three top problems facing CVC units, with both increasing year-on-year. These are symptoms of mandate ambiguity. When a unit has no clear sequencing logic, every decision with strategic implications requires resolution through corporate governance channels, which produces exactly the friction that the SVB report describes.
The consequences are structural: a third of all active CVCs were mothballed or shut down in the three years preceding the research by Strebulaev and Wang in MIT Sloan Management Review. The pattern they identified was not primarily about investment quality. It was about governance design.
What mandate ambiguity looks like in IC meetings
The IC meeting in a mandate-ambiguous CVC is recognisable by a specific failure mode: deal assessment that oscillates between financial and strategic criteria without a clear decision rule, and where the introduction of a new strategic concern can override a sound financial case (or vice versa) at any point in the discussion.
Four patterns are common. First, deals with strong strategic rationale but marginal financial cases attract disproportionate support from business unit executives on the IC. The investment team, which has built a financial case, finds that the IC applies a different standard when strategic excitement is present. Second, deals with strong financial cases but limited strategic read-through are systematically disadvantaged relative to independent VCs competing for the same allocation. The CVC cannot move as fast because the strategic review takes time; by the time the IC convenes, the round is over-allocated. Third, deals where the strategic and financial cases are in genuine tension, like the disruption scenario above, produce IC gridlock because neither the strategic nor the financial case is formally privileged. Fourth, post-investment, the portfolio company is asked to participate in commercial pilots, data-sharing arrangements, or strategic planning sessions that the investment thesis never contemplated, because the strategic obligations of the investment were never specified.
Arthur D. Little’s 2025 analysis of CVC mandates found that 47% of organisations place strategic objectives in primary position. More significantly, the research observed that organisations are actively moving away from hybrid mandates toward either a clearly strategic or clearly financial orientation. The data suggests the market is correcting toward clarity, even if governance documents have not yet caught up.
A mandate sequencing framework
The solution is not to choose between strategic and financial objectives. It is to specify, in writing, which objective governs at each type of decision point. This is different from declaring a primary mandate: a fund can genuinely pursue both strategic and financial value while still having clear sequencing logic for the moments when they conflict.
The four decision contexts that every CVC unit encounters, and the governing objective appropriate to each, are as follows:
| Decision Context | Description | Governing Objective | Rationale |
| Deal sourcing and initial screening | Which deals to pursue, what sectors to prioritise, which funnel to build | Strategic | The CVC’s comparative advantage over independent VCs is its corporate context. Strategic alignment defines where the unit has a right to win access and add distinctive value. |
| IC investment decision | Whether to invest, at what price, and on what terms | Financial | At the point of committing capital, financial discipline must govern. Strategic rationale is a filter, not a valuation override. A strategically interesting deal at a poor price is still a poor investment. |
| Commercial partnership and value-add | What the portfolio company receives from the corporate parent, and on what terms | Strategic (with founder consent) | Post-investment value creation is the CVC’s most important differentiator. It should be intentional, governed by strategic priorities, and always consensual. |
| Portfolio management and follow-on decisions | Reserve allocation, bridge extensions, follow-on timing | Financial | Capital allocation decisions must be evaluated on portfolio construction logic. Strategic interest in a company’s technology does not justify maintaining capital in a company that cannot reach its next milestone independently. |
Documenting this sequencing framework serves two additional functions beyond improving IC quality. For LP and board transparency, it provides a legible answer to the question: how does the unit decide what to invest in and when to exit? For the investment team, it removes the ambiguity that creates the three-hour IC discussions. When the decision context is an IC investment decision, the governing objective is financial. Strategic concerns are inputs to the initial screen, not veto instruments at the point of capital commitment.
This is not theoretical. The CVC units that most consistently deploy within the timelines that competitive rounds require are the ones with the most explicit sequencing logic. Speed is not a culture question. It is a governance question. When an IC can enter a meeting with a shared understanding of which objective governs this specific decision, the discussion becomes more focused, faster, and more defensible.
The Implication
The mandate design change that most immediately improves CVC decision quality and the unit’s relationship with the parent corporate is neither a governance restructuring nor a reporting change. It is the addition of a single sentence to the investment policy statement: one that specifies which objective governs IC investment decisions when strategic and financial assessments conflict.
For most CVC units, the right answer is financial governs at the point of capital commitment. Strategic rationale is the sourcing and screening logic. It determines which companies the unit should be in the room with. It is not a licence to fund a company at a price that financial analysis does not support, or to block a sound financial investment because strategic consensus cannot be reached in the time the round requires.
The parent corporate relationship improves for a structural reason: when the sequencing logic is explicit, the business unit executives on the IC understand what their role is. They are strategic intelligence, not decision-makers. The CVC team has the authority to move when the financial case is sound and the strategic screen has been passed. Disagreements that currently occupy three-hour IC meetings become thirty-minute reviews. That is not a process optimisation. It is the difference between a CVC unit that acts and one that deliberates.